Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 21, 2016

Spectratech develops OEG-16H to communicate with comatose patients

Japan-based medical technology company Spectratech has developed its fNIRS device, OEG-16H, an encephalography mechanism to measure changes in hemoglobin and apparent arterial oxygen saturation in the frontal lobe of comatose patients.

Spectagraph

Japan-based medical technology company Spectratech has developed its fNIRS device, OEG-16H, an encephalography mechanism to measure changes in hemoglobin and apparent arterial oxygen saturation in the frontal lobe of comatose patients.

The device is based on Spectratech-developed Ultrahigh SNR technology which can display ultra-weak pulse waves and allow users the ability to perform a multi-channel brain localisation analysis.

Its index of Apparent SpO2 (apparent arterial oxygen saturation) facilitates a better understanding of how to influence the actions from cerebral circulation / metabolism to brain function by the Ultrahigh SNR technology.

The easy to carry, battery-operated device includes a monitor, a main unit, head modules, software, optical phantom, BNC cable for external input, manual event trigger input, USB cable, and an AC adapter.

The Spectratech OEG-16 H can operate on Microsoft Windows 7 or 8 and its own dedicated software.

"The device translates brain waves into data allowing a simultaneous measurement of hemoglobin at multiple points."

The instrument offers constant connectivity with six light injection points, six optical light-receiving points, and 16-channel measure points in the lightweight head module.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

The device translates brain waves into data allowing a simultaneous measurement of hemoglobin at multiple points.

Additionally, the distributor allows medical technicians to implement hyperscanning.

Spectratech aims to interpret chemical changes in the brain by means of this fNIRS technology to establish patterns of communication with comatose patients.


Image: The Spectratech OEG-16 H tin use. Photo: courtesy of PRNewsFoto / Ampronix.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU